GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Epitomee Medical Ltd (OTCPK:EPTMF) » Definitions » EV-to-EBIT

EPTMF (Epitomee Medical) EV-to-EBIT : -8.92 (As of Sep. 27, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Epitomee Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Epitomee Medical's Enterprise Value is $53.85 Mil. Epitomee Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-6.03 Mil. Therefore, Epitomee Medical's EV-to-EBIT for today is -8.92.

The historical rank and industry rank for Epitomee Medical's EV-to-EBIT or its related term are showing as below:

EPTMF' s EV-to-EBIT Range Over the Past 10 Years
Min: -8.98   Med: 0.94   Max: 1.64
Current: -8.98

During the past 6 years, the highest EV-to-EBIT of Epitomee Medical was 1.64. The lowest was -8.98. And the median was 0.94.

EPTMF's EV-to-EBIT is ranked worse than
100% of 446 companies
in the Medical Devices & Instruments industry
Industry Median: 19.385 vs EPTMF: -8.98

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Epitomee Medical's Enterprise Value for the quarter that ended in Jun. 2024 was $4.52 Mil. Epitomee Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-6.03 Mil. Epitomee Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -133.53%.


Epitomee Medical EV-to-EBIT Historical Data

The historical data trend for Epitomee Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epitomee Medical EV-to-EBIT Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - - -20.74 -3.08 0.32

Epitomee Medical Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only - -3.08 - 0.32 -

Competitive Comparison of Epitomee Medical's EV-to-EBIT

For the Medical Devices subindustry, Epitomee Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epitomee Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Epitomee Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Epitomee Medical's EV-to-EBIT falls into.



Epitomee Medical EV-to-EBIT Calculation

Epitomee Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=53.850/-6.034
=-8.92

Epitomee Medical's current Enterprise Value is $53.85 Mil.
Epitomee Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epitomee Medical  (OTCPK:EPTMF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Epitomee Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 ) =EBIT / Enterprise Value (Q: Jun. 2024 )
=-6.034/4.51871252
=-133.53 %

Epitomee Medical's Enterprise Value for the quarter that ended in Jun. 2024 was $4.52 Mil.
Epitomee Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epitomee Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Epitomee Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Epitomee Medical Business Description

Traded in Other Exchanges
Address
Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.